Lepu Medical(SZ:300003) Xin Lang Cai Jing·2025-11-26 02:28Core Viewpoint - Lepu Medical has shown a significant increase in stock price and revenue growth, indicating a positive market sentiment and operational performance in the medical device sector [1][2]. Group 1: Stock Performance - On November 26, Lepu Medical's stock rose by 2.09%, reaching 16.13 CNY per share, with a trading volume of 86.74 million CNY and a turnover rate of 0.34%, resulting in a total market capitalization of 29.73 billion CNY [1]. - Year-to-date, Lepu Medical's stock price has increased by 46.00%, with a slight increase of 0.12% over the last five trading days, but a decline of 8.61% over the last 20 days and 18.90% over the last 60 days [1]. - The company has appeared on the "Dragon and Tiger List" once this year, with a net buy of 29.56 million CNY on June 4, accounting for 9.42% of total trading volume [1]. Group 2: Business Overview - Lepu Medical, established on June 11, 1999, and listed on October 30, 2009, is based in Changping District, Beijing, and operates in the medical device sector, including cardiac treatment products, new interventional therapies, in vitro diagnostic reagents, and medical product distribution [2]. - The company's revenue composition includes 52.72% from medical devices, 33.16% from pharmaceuticals, and 14.11% from medical services and health management [2]. - Lepu Medical is categorized under the pharmaceutical and biological industry, specifically in medical devices and consumables, with involvement in concepts such as brain engineering, blood oxygen monitors, artificial intelligence, smart healthcare, and innovative drugs [2]. Group 3: Financial Performance - For the period from January to September 2025, Lepu Medical reported a revenue of 4.939 billion CNY, reflecting a year-on-year growth of 3.20%, while the net profit attributable to shareholders was 982 million CNY, representing a year-on-year increase of 22.35% [2]. - Since its A-share listing, Lepu Medical has distributed a total of 4.957 billion CNY in dividends, with 2.058 billion CNY distributed over the past three years [3]. Group 4: Shareholder Information - As of September 30, 2025, Lepu Medical had 82,900 shareholders, a decrease of 17.13% from the previous period, with an average of 19,490 circulating shares per shareholder, an increase of 20.67% [2]. - The top ten circulating shareholders include notable entities such as Huabao Zhongzheng Medical ETF and Hong Kong Central Clearing Limited, with varying changes in their holdings compared to the previous period [3].